Tower Research Capital (TRC)’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Tower Research Capital (TRC)’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12	Closed	–	–	6847
2022 Q3	$0	Sell	12 -4	-25%	-$40	﹤0.01%	6860
2022 Q2	$0	Buy	+16	New	+$158	﹤0.01%	6943

Tower Research Capital (TRC)'s FLAC Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 12 shares.

Tower Research Capital (TRC) first reported a position in FLAC in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Tower Research Capital (TRC) reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 12 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022.
Tower Research Capital (TRC) first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q2 2022 and held it in 2 quarters.
Tower Research Capital (TRC)'s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $0 in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.